Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16

Aims To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results In the population-based Tromsø Study 2015–16 (attendance 65%...

Full description

Bibliographic Details
Published in:European Journal of Preventive Cardiology
Main Authors: Hopstock, LA, Morseth, B, Cook, S, Eggen, AE, Grimsgaard, S, Lundblad, MW, Løchen, M-L, Mathiesen, E, Nilsen, A, Njølstad, I
Format: Article in Journal/Newspaper
Language:English
Published: Oxford University Press (OUP) 2021
Subjects:
Online Access:http://hdl.handle.net/10044/1/88556
https://doi.org/10.1093/eurjpc/zwab050
id ftimperialcol:oai:spiral.imperial.ac.uk:10044/1/88556
record_format openpolar
spelling ftimperialcol:oai:spiral.imperial.ac.uk:10044/1/88556 2023-05-15T18:34:31+02:00 Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16 Hopstock, LA Morseth, B Cook, S Eggen, AE Grimsgaard, S Lundblad, MW Løchen, M-L Mathiesen, E Nilsen, A Njølstad, I 2021-03-12 http://hdl.handle.net/10044/1/88556 https://doi.org/10.1093/eurjpc/zwab050 en eng Oxford University Press (OUP) European Journal of Preventive Cardiology 2047-4873 http://hdl.handle.net/10044/1/88556 doi:10.1093/eurjpc/zwab050 © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com http://creativecommons.org/licenses/by-nc/4.0/ CC-BY-NC 370 362 Science & Technology Life Sciences & Biomedicine Cardiac & Cardiovascular Systems Cardiovascular System & Cardiology Epidemiology Cardiovascular disease Myocardial infarction Stroke Secondary prevention CORONARY-HEART-DISEASE COHORT PROFILE MANAGEMENT TRENDS Journal Article 2021 ftimperialcol https://doi.org/10.1093/eurjpc/zwab050 2022-03-31T22:40:56Z Aims To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed. Article in Journal/Newspaper Tromsø Imperial College London: Spiral Norway Tromsø European Journal of Preventive Cardiology 29 2 362 370
institution Open Polar
collection Imperial College London: Spiral
op_collection_id ftimperialcol
language English
topic Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Epidemiology
Cardiovascular disease
Myocardial infarction
Stroke
Secondary prevention
CORONARY-HEART-DISEASE
COHORT PROFILE
MANAGEMENT
TRENDS
spellingShingle Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Epidemiology
Cardiovascular disease
Myocardial infarction
Stroke
Secondary prevention
CORONARY-HEART-DISEASE
COHORT PROFILE
MANAGEMENT
TRENDS
Hopstock, LA
Morseth, B
Cook, S
Eggen, AE
Grimsgaard, S
Lundblad, MW
Løchen, M-L
Mathiesen, E
Nilsen, A
Njølstad, I
Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
topic_facet Science & Technology
Life Sciences & Biomedicine
Cardiac & Cardiovascular Systems
Cardiovascular System & Cardiology
Epidemiology
Cardiovascular disease
Myocardial infarction
Stroke
Secondary prevention
CORONARY-HEART-DISEASE
COHORT PROFILE
MANAGEMENT
TRENDS
description Aims To investigate European guideline treatment target achievement in cardiovascular risk factors, medication use, and lifestyle, after myocardial infarction (MI) or ischaemic stroke, in women and men living in Norway. Methods and results In the population-based Tromsø Study 2015–16 (attendance 65%), 904 participants had previous validated MI and/or stroke. Cross-sectionally, we investigated target achievement for blood pressure (<140/90 mmHg, <130/80 mmHg if diabetes), LDL cholesterol (<1.8 mmol/L), HbA1c (<7.0% if diabetes), overweight (body mass index (BMI) <25 kg/m2, waist circumference women <80 cm, men <94 cm), smoking (non-smoking), physical activity (self-reported >sedentary, accelerometer-measured moderate-to-vigorous ≥150 min/week), diet (intake of fruits ≥200 g/day, vegetables ≥200 g/day, fish ≥200 g/week, saturated fat <10E%, fibre ≥30 g/day, alcohol women ≤10 g/day, men ≤20 g/day), and medication use (antihypertensives, lipid-lowering drugs, antithrombotics, and antidiabetics), using regression models. Proportion of target achievement was for blood pressure 55.2%, LDL cholesterol 9.0%, HbA1c 42.5%, BMI 21.1%, waist circumference 15.7%, non-smoking 86.7%, self-reported physical activity 79%, objectively measured physical activity 11.8%, intake of fruit 64.4%, vegetables 40.7%, fish 96.7%, saturated fat 24.3%, fibre 29.9%, and alcohol 78.5%, use of antidiabetics 83.6%, lipid-lowering drugs 81.0%, antihypertensives 75.9%, and antithrombotics 74.6%. Only 0.7% achieved all cardiovascular risk factor targets combined. Largely, there was little difference between the sexes, and in characteristics, medication use, and lifestyle among target achievers compared to non-achievers. Conclusion Secondary prevention of cardiovascular disease was suboptimal. A negligible proportion achieved the treatment target for all risk factors. Improvement in follow-up care and treatment after MI and stroke is needed.
format Article in Journal/Newspaper
author Hopstock, LA
Morseth, B
Cook, S
Eggen, AE
Grimsgaard, S
Lundblad, MW
Løchen, M-L
Mathiesen, E
Nilsen, A
Njølstad, I
author_facet Hopstock, LA
Morseth, B
Cook, S
Eggen, AE
Grimsgaard, S
Lundblad, MW
Løchen, M-L
Mathiesen, E
Nilsen, A
Njølstad, I
author_sort Hopstock, LA
title Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
title_short Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
title_full Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
title_fullStr Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
title_full_unstemmed Treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the Tromsø Study 2015–16
title_sort treatment target achievement after myocardial infarction and ischaemic stroke: cardiovascular risk factors, medication use, and lifestyle: the tromsø study 2015–16
publisher Oxford University Press (OUP)
publishDate 2021
url http://hdl.handle.net/10044/1/88556
https://doi.org/10.1093/eurjpc/zwab050
geographic Norway
Tromsø
geographic_facet Norway
Tromsø
genre Tromsø
genre_facet Tromsø
op_source 370
362
op_relation European Journal of Preventive Cardiology
2047-4873
http://hdl.handle.net/10044/1/88556
doi:10.1093/eurjpc/zwab050
op_rights © The Author(s) 2021. Published by Oxford University Press on behalf of the European Society of Cardiology. This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited. For commercial re-use, please contact journals.permissions@oup.com
http://creativecommons.org/licenses/by-nc/4.0/
op_rightsnorm CC-BY-NC
op_doi https://doi.org/10.1093/eurjpc/zwab050
container_title European Journal of Preventive Cardiology
container_volume 29
container_issue 2
container_start_page 362
op_container_end_page 370
_version_ 1766219295176523776